Journal of Multiple Sclerosis and Neuroimmunology

Review Article

June 30, 2025

Diagnosis and Management of Neurological Immune Related Adverse Events

Jae-Won Hyun

J Mult Scler Neuroimmunol. 2025;16(1):1-7.

As the use of immune checkpoint inhibitors (ICIs) continues to rise, particularly in combination therapies, neurological immune-related adverse events (irAEs) are expected to become more prevalent in clinical practice. These...

Review Article

June 30, 2025

Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders

Ki Hoon Kim, Young Nam Kwon, Jun-Soon Kim, et al.

J Mult Scler Neuroimmunol. 2025;16(1):8-18.

Rare neurological disorders present significant challenges in diagnosis, treatment, and patient care. Despite their low prevalence, these conditions affect millions of people, necessitating collaboration between medical association and patient organizations...

Original Article

June 30, 2025

Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France

Grégoire Mercier, David Pau, Guillaume Bourel, et al.

J Mult Scler Neuroimmunol. 2025;16(1):19-25.

Background: The treatment landscape for multiple sclerosis (MS) includes a range of disease-modifying therapies (DMTs), from moderate- to high-efficacy agents. Understanding prescribing patterns following the launch of new treatments such...

Case Report

June 30, 2025

Clinical Manifestation and Prognosis of Overlapping Acute Motor Axonal Neuropathy and Acute Transverse Myelitis with Anti-GM1 and Anti-GD1a Antibodies: A Case Study

A Young Kim, Hong Keun Yoo, Jong Hyun Jeon, et al.

J Mult Scler Neuroimmunol. 2025;16(1):26-32.

Antibodies against GM1 and GD1a are closely associated with acute motor axonal neuropathy (AMAN). Patients simultaneously positive for both anti-GM1 and anti-GD1a antibodies are rare, and their clinical manifestations and...

Letter to the Editor

June 30, 2025

The Importance of Cautious Interpretation and Differential Diagnosis in Low-Titer MOG Antibody Positivity

Jae-Won Hyun, Ho Jin Kim

J Mult Scler Neuroimmunol. 2025;16(1):33-34.

Current Issue: Volume 16(1); Jun 2025

This archive contains links to the full-text of all issues of J Mult Scler Neuroimmunol.

Current issue

Volume 16(1); June

All issues

Vol. 16
2025

v.16(1)

Vol. 15
2024

v.15(1)

v.15(2)

Vol. 14
2023

v.14(1)

v.14(2)

Vol. 13
2022

v.13(1)

v.13(2)

Vol. 12
2021

v.12(1)

v.12(2)

Vol. 11
2020

v.11(1)

v.11(2)

Journal of Multiple Sclerosis2010 (v1 n1)

Vol. 10
2019

v.10(1)

v.10(2)

Vol. 9
2018

v.9(1)

v.9(2)

Vol. 8
2017

v.8(1)

v.8(2)

Vol. 7
2016

v.7(1)

v.7(2)

Vol. 6
2015

v.6(1)

v.6(2)

Vol. 5
2014

v.5(1)

v.5(2)

Vol. 4
2013

v.4(1)

v.4(2)

Vol. 3
2012

v.3(1)

v.3(2)

Vol. 2
2011

v.2(1)

v.2(2)

Vol. 1
2010

v.1(1)

v.1(2)

Volume 16, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

7,908	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
4,615	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
4,057	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
3,777	Rituximab Treatment for Neuroimmunologic Disorders
3,231	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By 4	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
Cited By 1	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	A Case of Post-Infective Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2025 by Korean Society of Neuroimmunology.